All Articles: Health Sciences News
Initial preclinical studies showed YCT-529 was 99% effective and 100% reversible with no side effects.
Findings can be used to decrease the negative impact on drug discovery of compounds that cause non-specific cell injury.
Research continues in collaboration with researchers at Harvard Medical School